Laurus Labs 

Laurus Labs Limited, founded in 2005, is an Indian pharmaceutical and biotechnology company that grew from active pharmaceutical ingredients and intermediates into finished dosages, CDMO services, and a biotech book under Laurus Bio. The leadership franchises it publishes are antiretroviral, oncology, cardiovascular, and gastroenterology APIs—hard-to-make molecules where process chemistry and regulatory history matter as much as a brand name on a strip. Finished-dosage and CDMO work sit beside that API core so a customer can buy a registered product or a custom campaign. Laurus Bio is the cell-and-gene and biologic layer the company uses to say it is no longer only a small-molecule shop. Geography is written as India plus the United Kingdom and Germany—commercial and development footprints rather than a tourism map. High-watermark compliance is the phrase Laurus uses for plants and quality systems that are supposed to satisfy inspectors the first time, not after a remediation tour. ESG reporting sits on the same corporate site as investor decks, so environmental and social claims are presented as part of the operating company, not as a side brochure. Those site maps and compliance claims belong on lauruslabs.com and in filings; they are cited here only as the company’s own markers. Customers are originators, generic houses, and public-health buyers who need ARV or oncology chemistry at a documented quality standard. Official product information is not medical advice. Labels, licensed indications, and a physician decide what a patient takes. API and CDMO pages describe chemistry and capacity for qualified customers; they are not consumer dosing guides. Official LinkedIn, X, and Facebook channels carry plant films, pipeline colour, and careers news. They are not adverse-event desks, pharmacy counters, or places to share prescriptions, batch records, or personal health data. Specifications, safety reports, and investor facts belong on lauruslabs.com and on the secretarial and investor-relations addresses the company publishes. Follow the pages for a 2005 Hyderabad-rooted manufacturer that still presents ARV, oncology, and CDMO chemistry as the point of the enterprise, then verify every site and franchise claim at the source.